Ensysce Biosciences, Inc.ENSCEarnings & Financial Report
Nasdaq · Health Care · Pharmaceutical Preparations
Ensysce Biosciences, Inc. is a clinical-stage biotechnology firm specializing in developing innovative prodrug therapies for pain management and oncology indications. Its proprietary platform is designed to reduce opioid abuse risks while enhancing treatment efficacy, targeting global healthcare and pharmaceutical markets with a focus on unmet clinical needs.
Top Holders
| Holder | % Owned | Shares | Change | As of |
|---|---|---|---|---|
| NOS. OF ABOVE PERSONS | 9.90% | 1.5M | — | 2024-11-06 |
| Perceptive Advisors LLC | 8.70% | 1.3M | — | 2024-10-29 |
| OF ABOVE PERSONS | 7.10% | 983.5K | — | 2024-11-14 |
| Bob | 5.70% | 161.6K | — | 2023-07-18 |
| Lincoln Park Capital Fund, LLC | 3.79% | 124.0K | — | 2024-02-14 |